Literature DB >> 26739038

Short children with a low midupper arm circumference respond to food supplementation: an observational study from Burkina Faso.

Christian Fabiansen1, Kevin Pq Phelan2, Bernardette Cichon3, Christian Ritz3, André Briend4, Kim F Michaelsen3, Henrik Friis3, Susan Shepherd5.   

Abstract

BACKGROUND: The management of children with moderate acute malnutrition (MAM) is based on food supplementation in outpatient programs. When midupper arm circumference (MUAC) is used as the sole admission criterion, it is common practice to exclude children with lengths <67 cm from treatment. The WHO calls for research to determine the treatment effect among children with MAM included by MUAC and aged ≥6 mo with lengths <67 cm.
OBJECTIVE: We hypothesized that among children given supplementary feeding based on an MUAC of 115-124 mm as the sole criterion, there would be no difference in growth rate between children <67 cm and those ≥67 cm in length at program admission.
DESIGN: This was an observational study nested in a randomized trial that investigated the effectiveness of new formulations of corn-soy blend and lipid-based nutrient supplements. Children aged 6-23 mo were included if their MUAC was between 115 and 124 mm but with a weight-for-height z score (WHZ) ≥-2. This cohort was divided into 2 groups by length at admission: <67 cm ("short") and ≥67 cm ("long"). Linear mixed-effects models and regression models were used to compare gains in weight and MUAC while adjusting for intervention, season, sex, age, and site.
RESULTS: Weight-gain velocity (expressed as g · kg(-1) · d(-1)) and MUAC-gain velocity (expressed as 0.01 mm · cm(-1) · d(-1)) were not different between short and long children. Weight-gain velocity was slightly higher in the shortest quartile of length (P = 0.03), whereas there was no effect modification by stunting across length quartiles (P = 0.32).
CONCLUSIONS: We found no evidence of a difference in percentage of weight gain or weight-gain velocity during supplementary feeding in short or long children aged 6-23 mo. We recommend a policy change to include children <67 cm in supplementary feeding programs if their MUAC is between 115 and 124 mm and their WHZ is ≥-2. This could benefit millions of children currently excluded from supplementary feeding. This trial was registered at www.controlled-trials.com as ISRCTN42569496.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  MUAC; moderate acute malnutrition; stunting; treatment; undernutrition

Mesh:

Year:  2016        PMID: 26739038     DOI: 10.3945/ajcn.115.124644

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

1.  Predictors of time to recovery and non-response during outpatient treatment of severe acute malnutrition.

Authors:  Suvi T Kangas; Cécile Salpéteur; Victor Nikièma; Christian Ritz; Henrik Friis; André Briend; Pernille Kaestel
Journal:  PLoS One       Date:  2022-05-31       Impact factor: 3.752

2.  Correlates of whole-blood polyunsaturated fatty acids among young children with moderate acute malnutrition.

Authors:  C W Yaméogo; B Cichon; C Fabiansen; M J H Rytter; D Faurholt-Jepsen; K D Stark; A Briend; S Shepherd; A S Traoré; V B Christensen; K F Michaelsen; H Friis; L Lauritzen
Journal:  Nutr J       Date:  2017-07-13       Impact factor: 3.271

3.  Correlates of Physical Activity among Young Children with Moderate Acute Malnutrition.

Authors:  Charles W Yaméogo; Bernardette Cichon; Christian Fabiansen; Ann-Sophie Iuel-Brockdorf; Susan Shepherd; Suzanne Filteau; Alfred S Traoré; Vibeke B Christensen; Kim F Michaelsen; Soren Brage; Henrik Friis; Daniel Faurholt-Jepsen
Journal:  J Pediatr       Date:  2016-11-18       Impact factor: 4.406

Review 4.  Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review.

Authors:  Tarun Gera; Juan Pablo Pena-Rosas; Evelyn Boy-Mena; Harshpal S Sachdev
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

5.  Does treatment of short or stunted children aged 6-59 months for severe acute malnutrition using ready to use therapeutic food make them overweight? Data from Malawi.

Authors:  Paul Binns; Mark Myatt
Journal:  Arch Public Health       Date:  2018-12-13

6.  MUAC as the sole discharge criterion from community-based management of severe acute malnutrition in Burkina Faso.

Authors:  Sheila Isanaka; Kerstin E Hanson; Severine Frison; Christopher T Andersen; Sandra Cohuet; Rebecca F Grais
Journal:  Matern Child Nutr       Date:  2018-10-10       Impact factor: 3.092

Review 7.  The relationship between wasting and stunting in young children: A systematic review.

Authors:  Susan Thurstans; Natalie Sessions; Carmel Dolan; Kate Sadler; Bernardette Cichon; Sheila Isanaka; Dominique Roberfroid; Heather Stobaugh; Patrick Webb; Tanya Khara
Journal:  Matern Child Nutr       Date:  2021-09-05       Impact factor: 3.092

8.  The relationship between wasting and stunting in Cambodian children: Secondary analysis of longitudinal data of children below 24 months of age followed up until the age of 59 months.

Authors:  Mueni Mutunga; Alexandra Rutishauser-Perera; Arnaud Laillou; Sophonneary Prak; Jacques Berger; Frank T Wieringa; Paluku Bahwere
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

9.  Mothers screening for malnutrition by mid-upper arm circumference is non-inferior to community health workers: results from a large-scale pragmatic trial in rural Niger.

Authors:  Franck G B Alé; Kevin P Q Phelan; Hassan Issa; Isabelle Defourny; Guillaume Le Duc; Geza Harczi; Kader Issaley; Sani Sayadi; Nassirou Ousmane; Issoufou Yahaya; Mark Myatt; André Briend; Thierry Allafort-Duverger; Susan Shepherd; Nikki Blackwell
Journal:  Arch Public Health       Date:  2016-09-06

10.  Fortified blended flour supplements displace plain cereals in feeding of young children.

Authors:  Ilana R Cliffer; William A Masters; Beatrice L Rogers
Journal:  Matern Child Nutr       Date:  2020-09-29       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.